Please see below a list of Dr. Bhatia's external professional relationships and disclosures for the calendar year 2024: 

BOARD MEMBER: Brown University, Vertex Pharmaceuticals*, Port Therapeutics*, Ropirio Therapeutics*

ADVISORY ROLES: Global Oncology, Sunbird Bio*, Satellite Bio*, Matrisome Bio*, Xilio Therapeutics,  Danaher, Catalio Capital, Pictet, Ochre Bio, Amplifyer Bio*, Earli Inc., Brigham Research Institute/Brigham and Women’s Hospital, Impilo Therapeutics

CONSULTING: Moderna Therapeutics

*Dr. Sangeeta Bhatia holds equity in these institutions